EPISODE · Sep 15, 2021 · 46 MIN
45. Psycholytic therapy with MDMA and LSD with Dr Peter Gasser
from The Drug Science Podcast · host Drug Science
Today’s episode features Dr Peter Gasser, the president of the Swiss Medical Society for Psycholytic Therapy. Professor Nutt and Dr Gasser talk about the rather unusual and innovative attitude to psychedelic research in Switzerland. How can Britain learn from the Swiss? What are the drug policies in the Albert Hofmann’s - the discoverer of LSD - country? Dr Peter Gasser is a Swiss psychiatrist and psychotherapist and the President of the Swiss Medical Society for Psycholytic Therapy since 1997. After LSD was criminalized worldwide he was the first person to conduct research on psychedelic-assisted psychotherapy. Additionally, he holds a permission for and provides treatment using MDMA and LSD. MDMALSDSwiss Medical Society for Psycholytic TherapyInternational Symposium on the Occasion of the 100th Birthday of Albert HofmannAlbert Hofmann PsilocybinPost-traumatic stress disorderMAPS - Multidisciplinary Association for Psychedelic StudiesWar on drugs - US political campaign The Psychedelic Renaissance Pilot study on LSD-Assisted Psychotherapy for Anxiety Associated With Life-threatening DiseasesEnd of life anxiety Obsessive-compulsive disorderCluster headachePsycholytic therapy with MDMA and LSD in Switzerland - MAPS article ★ Support this podcast ★
Embed this episode
What this episode covers
Dr Peter Gasser is one of the 15-20 Swiss psychiatrists that are legally allowed to prescribe LSD/MDMA-assisted psychotherapy outside of clinical research.
Ready to play
45. Psycholytic therapy with MDMA and LSD with Dr Peter Gasser
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.